Timothy Waxweiler, MD
Assistant Professor, Radiation Oncology
Medical School:
- MD, Emory University School of Medicine (2011)
- BSE, University of Michigan (MI) (2006)
- Presbyterian-St Luke's Medical Center Program (2012)
- University of Colorado, Chief Resident, Radiation Oncology (2016)
Professional Titles
- Assistant Professor
Publications
- Darragh LB, Knitz MM, Hu J, Clambey ET, Backus J, Dumit A, Samedi V, Bubak A, Greene C, Waxweiler T, Mehrotra S, Bhatia S, Gadwa J, Bickett T, Piper M, Fakhoury K, Liu A, Petit J, Bowles D, Thaker A, Atiyeh K, Goddard J, Hoyer R, Van Bokhoven A, Jordan K, Jimeno A, D'Alessandro A, Raben D, McDermott JD, Karam SD. Author Correction: A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC. Nat Cancer. 2023 Jan;4(1):148. PubMed PMID: 36577897
- Fakhoury KR, Schubert LK, Coyne MD, Aldridge W, Zeiler S, Stuhr K, Waxweiler TV, Robin TP, Schefter TE, Kavanagh BD, Nath SK. Practical Implementation of Emergent After-Hours Radiation Treatment Process Using Remote Treatment Planning on Optimized Diagnostic CT Scans. Cureus. 2022 Dec;14(12):e33100. PubMed PMID: 36721584
- Darragh LB, Knitz MM, Hu J, Clambey ET, Backus J, Dumit A, Samedi V, Bubak A, Greene C, Waxweiler T, Mehrotra S, Bhatia S, Gadwa J, Bickett T, Piper M, Fakhoury K, Liu A, Petit J, Bowles D, Thaker A, Atiyeh K, Goddard J, Hoyer R, Van Bokhoven A, Jordan K, Jimeno A, D'Alessandro A, Raben D, McDermott JD, Karam SD. A phase I/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC. Nat Cancer. 2022 Nov;3(11):1300-1317. PubMed PMID: 36434392
- Vinogradskiy Y, Castillo R, Castillo E, Schubert L, Jones BL, Faught A, Gaspar LE, Kwak J, Bowles DW, Waxweiler T, Dougherty JM, Gao D, Stevens C, Miften M, Kavanagh B, Grills I, Rusthoven CG, Guerrero T. Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):986-995. PubMed PMID: 34767934
- Amirault M, Choo S, Waxweiler T, Weisdack SD, Breaker K, Flaig TW, Lam ET. Tumor flare of brain metastases upon dose interruption of sunitinib in a patient with metastatic renal cell carcinoma. Cancer Treat Res Commun. 2021;27:100367. PubMed PMID: 33839514
- Vinogradskiy Y, Castillo R, Castillo E, Schubert L, Jones BL, Faught A, Gaspar LE, Kwak J, Bowles DW, Waxweiler T, Dougherty JM, Gao D, Stevens C, Miften M, Kavanagh B, Grills I, Rusthoven CG, Guerrero T. Results of a Multi-institutional Phase 2 Clinical Trial for 4DCT-ventilation Functional Avoidance Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021 Nov 9. [Epub ahead of print] PubMed PMID: 34767934
- Vinogradskiy Y, Rusthoven CG, Schubert L, Jones B, Faught A, Castillo R, Castillo E, Gaspar LE, Kwak J, Waxweiler T, Dougherty M, Gao D, Stevens C, Miften M, Kavanagh B, Guerrero T, Grills I. Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1357-1365. PubMed PMID: 30353873
- Karam SD, Reddy K, Blatchford PJ, Waxweiler T, DeLouize AM, Oweida A, Somerset H, Marshall C, Young C, Davies KD, Kane M, Tan AC, Wang XJ, Jimeno A, Aisner DL, Bowles DW, Raben D. Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. Clin Cancer Res. 2018 Oct 15;24(20):4949-4959. PubMed PMID: 30084837
- Amini A, Waxweiler TV, Maroni PD, Kessler ER, Cost CR, Greffe BS, Garrington TP, Liu AK, Cost NG. Survival outcomes of adolescent and adult patients with non-seminomatous testicular germ-cell tumors: A population-based study. J Pediatr Urol. 2016 Dec;12(6):405.e1-405.e9. PubMed PMID: 27544905
- Amini A, Waxweiler TV, Brower JV, Jones BL, McDermott JD, Raben D, Ghosh D, Bowles DW, Karam SD. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base. JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110. PubMed PMID: 27541166
- Amini A, Rusthoven CG, Waxweiler TV, Jones BL, Fisher CM, Karam SD, Raben D. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States. J Am Acad Dermatol. 2016 Feb;74(2):309-16. PubMed PMID: 26670715
- Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2016 May;195(5):1453-8. PubMed PMID: 26576709
Practice Locations
UCHealth Radiation Oncology - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0100
UCHealth Radiation Oncology - Cherry Creek Medical Center
100 Cook Street
Suite 102
Denver, CO 80206
720-516-9422
Rocky Mountain Gamma Knife Center - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-1290
Hospital Affiliation
1665 Aurora Ct
Aurora, CO 80045
720-848-0100
UCHealth Radiation Oncology - Cherry Creek Medical Center
100 Cook Street
Suite 102
Denver, CO 80206
720-516-9422
Rocky Mountain Gamma Knife Center - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-1290
Hospital Affiliation
- UCHealth Memorial Hospital
- University of Colorado Hospital
Specialty Information
Specialties
- Radiation Oncology, Board Certification (2017)
- Cancers
- Cancers - Radiation Therapy
- Cancers - Brain Cancer
- Cancers - Head and Neck Cancer
- Cancers - Prostate Cancer
- Cancers - Skin Cancer
- Cancers - Lung Cancer
- Cancers - Breast Cancer
- Cancers - Kidney Cancer
- Cancers - Melanoma
- Cancers - Thoracic (Tracheal, Esophageal)
- Cancers - Urologic Cancer
Clinical Interests
I enjoy treating all forms of cancer and benign conditions for which we use radiation. My particular interests are brain, spine, head and neck, skin, breast, prostate, and thoracic tumors.
Care Philosophy
I strive to offer each of my patients and their families the best possible care. I think this starts with listening and prioritizing their values. Our team then works towards a treatment plan that meets these values while employing current evidenced based practices. I aim to remain available and support my patients and families throughout their treatments and follow-up. My primary practice is located at Cherry Creek Medical Center, and I also spend time at our Anschutz Medical Campus location.
I enjoy treating all forms of cancer and benign conditions for which we use radiation. My particular interests are brain, spine, head and neck, skin, breast, prostate, and thoracic tumors.
Care Philosophy
I strive to offer each of my patients and their families the best possible care. I think this starts with listening and prioritizing their values. Our team then works towards a treatment plan that meets these values while employing current evidenced based practices. I aim to remain available and support my patients and families throughout their treatments and follow-up. My primary practice is located at Cherry Creek Medical Center, and I also spend time at our Anschutz Medical Campus location.
General Information
Medical Schools:
- MD, Emory University School of Medicine (2011)
Undergraduate Schools:
- BSE, University of Michigan (MI) (2006)
Internships:
- Presbyterian-St Luke's Medical Center Program (2012)
Residency Programs:
- University of Colorado, Chief Resident, Radiation Oncology (2016)